Total Payments
$19,308
2024 Payments
$5,008
Companies
60
Transactions
623
Medicare Patients
7,732
Medicare Billing
$501,774
Payment Breakdown by Category
Food & Beverage$11,670 (60.4%)
Other$5,256 (27.2%)
Consulting$2,180 (11.3%)
Education$201.50 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,670 | 607 | 60.4% |
| Current or prospective ownership or investment interest | $5,237 | 2 | 27.1% |
| Consulting Fee | $2,180 | 1 | 11.3% |
| Education | $201.50 | 7 | 1.0% |
| Entertainment | $18.93 | 1 | 0.1% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
General
$19,308
618 transactions
Ownership
$0
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $5,237 | 7 | $0 (2021) |
| Janssen Biotech, Inc. | $2,568 | 17 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,593 | 50 | $0 (2024) |
| Astellas Pharma US Inc | $1,446 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,219 | 60 | $0 (2024) |
| PFIZER INC. | $809.24 | 90 | $0 (2024) |
| Merck Sharp & Dohme LLC | $755.22 | 35 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $520.27 | 32 | $0 (2024) |
| Axonics, Inc. | $431.30 | 31 | $0 (2024) |
| UROVANT SCIENCES INC | $429.26 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,008 | 110 | Janssen Biotech, Inc. ($2,413) |
| 2023 | $2,238 | 113 | AstraZeneca Pharmaceuticals LP ($263.64) |
| 2022 | $2,233 | 126 | Dendreon Pharmaceuticals LLC ($371.41) |
| 2021 | $1,548 | 90 | AstraZeneca Pharmaceuticals LP ($276.51) |
| 2020 | $336.88 | 20 | Astellas Pharma US Inc ($121.47) |
| 2019 | $973.14 | 49 | Astellas Pharma US Inc ($256.63) |
| 2018 | $917.32 | 51 | PFIZER INC. ($238.95) |
| 2017 | $6,053 | 64 | Innovative Medical Technologies, LLC ($5,237) |
All Payment Transactions
623 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/11/2024 | COLOPLAST CORP | Porges Coloplast (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Endourology | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.35 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/28/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Oncology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: HORMONE THERAPY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $146.59 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 10/24/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $79.71 | General |
| 10/24/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $48.87 | General |
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Oncology | ||||||
| 10/14/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Immunotherapy | ||||||
| 10/09/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Immunotherapy | ||||||
| 10/02/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Urology | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Oncology | ||||||
| 09/23/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $147.15 | General |
| Category: UROLOGY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Oncology | ||||||
| 09/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,024 | 7,522 | $542,800 | $139,298 |
| 2022 | 25 | 1,891 | 7,124 | $458,653 | $117,352 |
| 2021 | 28 | 1,921 | 7,381 | $472,820 | $132,257 |
| 2020 | 32 | 1,896 | 5,760 | $458,175 | $112,866 |
Total Patients
7,732
Total Services
27,787
Medicare Billing
$501,774
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 344 | 440 | $92,400 | $38,597 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 238 | 245 | $34,055 | $12,966 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $27,132 | $9,746 | 35.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 125 | 157 | $91,845 | $9,262 | 10.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 31 | 31 | $18,414 | $8,145 | 44.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 36 | 41 | $23,985 | $7,134 | 29.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 75 | 81 | $25,596 | $5,977 | 23.4% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 28 | 30 | $24,000 | $5,257 | 21.9% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 16 | 2,323 | $8,711 | $5,245 | 60.2% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 17 | 71 | $39,263 | $4,625 | 11.8% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 28 | 28 | $11,732 | $4,050 | 34.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 72 | 99 | $8,316 | $3,777 | 45.4% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 20 | 28 | $16,464 | $3,594 | 21.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $7,868 | $2,700 | 34.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 27 | 55 | $13,695 | $2,352 | 17.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 22 | 22 | $7,194 | $2,160 | 30.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 29 | 29 | $5,829 | $1,849 | 31.7% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 38 | 46 | $25,714 | $1,434 | 5.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 15 | $3,409 | $1,371 | 40.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 16 | 17 | $8,075 | $1,273 | 15.8% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2023 | 11 | 45 | $2,945 | $1,078 | 36.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 377 | 491 | $7,365 | $1,074 | 14.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,150 | $1,023 | 32.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 116 | 127 | $5,207 | $975.39 | 18.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 16 | 16 | $7,616 | $756.02 | 9.9% |
About Dr. Kenneth Lessans, MD
Dr. Kenneth Lessans, MD is a Urology healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992736169.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Lessans, MD has received a total of $19,308 in payments from pharmaceutical and medical device companies, with $5,008 received in 2024. These payments were reported across 623 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($11,670).
As a Medicare-enrolled provider, Lessans has provided services to 7,732 Medicare beneficiaries, totaling 27,787 services with total Medicare billing of $501,774. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Lancaster, PA
- Active Since 07/06/2006
- Last Updated 10/03/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1992736169
Products in Payments
- PROVENGE (Drug) $1,593
- LYNPARZA (Drug) $1,152
- XTANDI (Drug) $798.37
- GEMTESA (Drug) $622.45
- KEYTRUDA (Biological) $585.22
- BOTOX (Biological) $405.37
- Xtandi (Drug) $398.37
- ORGOVYX (Drug) $391.65
- Myrbetriq (Drug) $391.33
- MYRBETRIQ (Drug) $310.10
- Axonics (Device) $270.00
- FIRMAGON (Drug) $230.80
- Noctiva (Drug) $229.77
- Nubeqa (Drug) $197.38
- SpeediCath (Device) $188.27
- Xofigo (Drug) $188.22
- Axonics r-SNM System (Device) $178.12
- ERLEADA (Drug) $175.17
- JELMYTO (Drug) $158.19
- AQUABEAM SYSTEM (Device) $147.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lancaster
Paul Sieber, M.d, M.D
Urology — Payments: $697,313
Urology $697,313
Pradeep Pandya, M.d, M.D
Urology — Payments: $21,579
Urology $21,579
Christopher Miller, M.d, M.D
Urology — Payments: $19,062
Urology $19,062
Dr. Christopher Woodard, M.d, M.D
Urology — Payments: $10,549
Urology $10,549
Dr. Robert Hong, M.d, M.D
Urology — Payments: $10,456
Urology $10,456
David Svetec, Md, MD
Urology — Payments: $9,483
Urology $9,483